Evaluation of dynamic thiol/disulfide homeostasis in patients with Familial Mediterranean Fever
Öz
Introduction: Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that includes recurrent episodes of serosal inflammation, with accompanying fever. Thiol/disulfide homeostasis, marker of oxidative stress, is associated with an increase in inflammatory cytokines in many inflammatory diseases. The aim was to evaluate the dynamic thiol/disulfide homeostasis in patients with FMF during attack free period.
Material and method: In our study, 60 patients with FMF during attack free period, 60 patients with Ankylosing Spondylitis (AS) during inactive period and 60 age-and sex matched controls were included. Native thiol, total thiol and disulfide levels were measured by using the Erel and Neselioglu method.
Result: Total thiol and disulfide levels were found to be significantly lower in FMF group compared to healthy controls. Native thiol levels were detected to be significantly higher in FMF group compared to AS group. However, no significant difference was observed in total thiol levels between FMF and AS group. Ratios obtained using plasma native thiol, total thiol, and disulfide levels differed significantly between the FMF, AS and the control groups.
Conclusion: The lower thiol level of FMF group compared to AS and controls suggests that the thiol / disulfide balance is affected differently in diseases with different pathophysiology. Although the disease is in clinically inactive period, inflammation may continue at different levels in different rheumatic diseases.
Anahtar Kelimeler
Kaynakça
- 1. Özen S, Batu ED, Demir S. Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management. Front Immunol. 2017; 8: 253.
- 2. Van der Hilst JCh, Moutschen M, Messiaen PE, Lauwerys BR, Vanderschueren S. Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.Biologics. 2016; 10: 75-80.
- 3. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016; 75(4): 644-51.
- 4. Guzel S, Andican G, Seven A, Aslan M, Bolayirli M, Guzel EC, et al. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF). Mod Rheumatol 2012; 22: 431-7.
- 5. Yildirim K, Uzkeser H, Keles M, Karatay S, Kiziltunc A, Kaya MD, et al. Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever.Biochem Med (Zagreb). 2012; 22(1): 109-13.
- 6. Şahin A, Erten Ş, Altunoğlu A, Işıkoğlu S, Neşelioğlu S, Ergin M, et al. Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period. Acta Reumatol Port 2014; 39: 316-21.
- 7. Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun. 2002; 3(1): 43-5.
- 8. Chen W, Zhao Y, Seefeldt T, Guan X. Determination of thiols and disulfides via HPLC quantification of 5-thio-2-nitrobenzoic acid. J. Pharm. Biomed. Anal. 2008; 48(5): 1375-80.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Atalay Doğru
*
0000-0002-9797-1182
Türkiye
Salim Neşelioğlu
Bu kişi benim
0000-0002-0974-5717
Yayımlanma Tarihi
6 Aralık 2018
Gönderilme Tarihi
21 Eylül 2018
Kabul Tarihi
22 Ekim 2018
Yayımlandığı Sayı
Yıl 2018 Cilt: 9 Sayı: 3
